|
ENGLISH Disclaimer For the correctness and completeness of the information on our website, we assume no liability. This site contains information about Implen. The content of these sites neither is complete, nor is an evaluation of other companies mentioned. Under no circumstances this information may be used without our prior express written consent. Privacy: We would like to point out that privacy in some cases can not be guaranteed. E-mails sent to us, may be used in any way by us. Copyright All content, forms, graphics and structure of this web site are copyright of Implen. Reproduction, modification, use or further processing of the information published here, as well as putting a link to our website without our prior express written consent is prohibited. Links The links are used on our website do not represent any rating. The completeness and timeliness of the information is not checked by us. For the consequences of any kind arising from use of this information, we assume no responsibility. These sites are maintained by other companies. Editor Implen GmbH Schatzbogen 52 D-81829 München Tel: 49 (0) 89 7263718 0 Fax: 49 (0) 89 7263718 54 Email info@implen.de Managing Directors: Martin Sahiri Dr. Thomas Sahiri Commercial Register B of the Munich District Court HRB 148 607 Ust.-Id.-Nr. DE229960428 |
DEUTSCH Haftungsausschluss Für die Richtigkeit und Vollständig der Angaben auf unserer Homepage übernehmen wir keine Haftung. Diese Homepage enthält Informationen über die Implen GmbH. Der Inhalt dieser Seiten ist weder vollständig, noch stellt er eine Bewertung anderer genannter Unternehmen dar. Keinesfalls dürfen die Informationen ohne unsere vorherige ausdrückliche schriftliche Zustimmung benutzt werden. Datenschutz: Wir möchten darauf hinweisen, dass der Datenschutz in einigen Fällen nicht umfassend gewährleistet werden kann. An uns gerichtete E-mails, dürfen von uns in jeglicher Art und Weise verwendet werden. Copyright Sämtliche Inhalte, Formulare, Grafiken und die Struktur dieser Website unterliegen dem Urheberrecht der Implen GmbH. Eine Vervielfältigung, Änderung, Verwendung oder Weiterverarbeitung der hier veröffentlichten Informationen, sowie das Setzen eines Links zu unserer Homepage, ohne unsere vorherige ausdrückliche schriftliche Zustimmung, ist untersagt. Links Die auf unserer Homepage verwendeten Links stellen keine Bewertung dar. Die Vollständigkeit und Aktualität der Informationen wird nicht von uns geprüft. Für Folgen jeglicher Art, die aus der Benutzung dieser Informationen entstehen übernehmen wir keine Verantwortung. Diese Homepages werden von anderen Unternehmen gepflegt. Herausgeber Implen GmbH Schatzbogen 52 D-81829 München Tel.: +49 (0)89 7263718 0 Fax: +49 (0)89 7263718 54 Email info@implen.de Geschäftsführer: Martin Sahiri Dr. Thomas Sahiri Handelsregister B des Amtsgerichts München HRB 148607 Ust.-ID.-Nr. DE229960428 |
Nucleic Acid Analysis |
Protein & Peptide Analysis |
Complete solution for ultra low and standard volume applications
The NanoPhotometer® is equipped with pre-programmed Applications for highest user comfort.
| Nucleic acids | dsDNA, ssDNA, RNA, and Oligonucleotides, Labeling efficiency |
| Proteins | Protein UV (A280), Protein Dye, Bradford, Lowry, BCA, Biuret |
| Cell density | for bacterial cell cultures |
| General Functions | Specified wavelengths, wavescan, kinetics, standard curve |

It is well established that for determination nucleic acid concentration in solution the absorbance at wavelength 260 nm (A260) is used. The function describing the concentration to absorbance relation is the Lambert-Beer Law: A = e * c * d.


The absorbance reading of dye labelled nucleic acids at 260 nm is affected by the dye contribution. To obtain accurate concentration values, the contribution has to be eliminated using correction factors.

The BCA method depends on reaction between Cupric ions and peptide bonds, but in addition combines this reaction with the detection of Cuprous ions using bicinchoninic acid (BCA), giving an absorbance maximum at 562 nm.
The Bradford method depends on quantitating the binding of a dye, Coomassie Brilliant Blue, to an unknown protein and comparing this binding to that of different, known concentrations of a standard protein at 595 nm (default setting); this is usually BSA, bovine serum albumin.
The Lowry method depends on quantifying the colour obtained from the reaction of Folin-Ciocalteu phenol reagent with the tylsryl residues of an unknown protein and comparing with those derived from a standard curve of a standard protein at 750nm; this is usually BSA, bovine serum albumin
The Biuret method measures the reaction between Cupric ions and peptide bonds in an alkali solution, resulting in the formation of a complex absorbing at 546 nm.
The method OD 600 is used to determinate the absorbance at 600 nm. Bacterial cell cultures are routinely grown until the absorbance at 600 nm (known as OD600; default setting) reaches approximately 0.4 prior to induction or harvesting. A linear relationship exists between cell number (density) and OD 600 up to approx. 0.6.
The feature Single Wavelength allows simple absorbance (Abs) or transmission (%T) measurements at a single user defined wavelength. The result windows shows the amount of light passed through a sample relative to a reference.
The feature Concentration determines the concentration of samples from a single wavelength reading as a Colorimetric assay.
The feature Wavescan records an absorption (Abs) or transmission (%T) spectrum between two user defined wavelengths, maximum range 190 nm to 1100nm.
The feature Kinetics performs a colorimetric assay which follows the change in absorbance as a function of time at fixed wavelength.
The feature Standard Curve is a colorimetric assay at a single wavelength based on a user programmed curve.